
The Daily Biotech Pulse: Gilead"s Q2, Syndax Breast Cancer Drug Setback, Synergy Pharma On Brink Of Default
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting 52-week highs on Oct. 26) read more.....»»
This tiny biotech spun a quick $2 billion from $12 million
Endocyte licensed a prostate cancer drug a year ago for an upfront payment of $12 million. Now, it’s being bought by the Swiss pharma giant Novartis for more than $2 billion......»»
Cannabis Watch: Marijuana stocks to watch: Meet the drugmaker making cannabis-based medicines for autism, cancer and more
Drugmakers commonly make their medicines synthetically — think a lab, not a greenhouse. But because its medications employ cannabinoids, the U.K.-based GW Pharma also grows it own cannabis plants......»»
Drug Stocks Q1 Earnings to Watch on May 1: PFE, MRK & More
Four pharma/biotech companies are set to release earnings .....»»
Metals Stocks: Gold hovers near 10-month high as investors watch trade talks, Fed minutes
Gold edges higher Wednesday as bulls look to build on a rally that lifted the yellow metal to its highest finish since April a day earlier......»»
The Daily Biotech Pulse: Teva Settles With FTC, Setback For Merck In Liver Cancer Trial, Sienna Biopharma Offering
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Feb. 19) Alector Inc (NASDAQ: ALEC) (IPOed early Febru.....»»
The Daily Biotech Pulse: Teva Settles With FTC, Setback For Merck In Liver Cancer Trial, Sienna Biopharma Offering
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Feb. 19) read more.....»»
Europe Markets: European stocks hold onto 4-month highs; Wirecard soars
European markets were mostly down on Monday, after last week’s highs, as investor continue to watch trade negotiations between the U.S. and China unfold.....»»
Europe Markets: European stocks hover at 4-month highs on hopes for more trade progress; Wirecard surges
European markets were mostly down on Monday, after last week’s highs, as investor continue to watch trade negotiations between the U.S. and China unfold.....»»
3 Top Biotech Stocks to Buy in February
Here's why Viking Therapeutics, Cambrex, and Sarepta Therapeutics are all solid biotech plays this month......»»
The Daily Biotech Pulse: Partial Clinical Hold On Advaxis Cervical Cancer Drug, Ohr"s Reverse Split, Ironwood Starts Phase 1 Trial
Here's a roundup of top developments in the biotech space over the last 24 hours. No biotech stocks hit 52-week highs Wednesday. Down In The Dumps (Biotech stocks hitting 52-week lows on Jan. 23) read more.....»»
2 Biotech Stocks On Watch Early In The Week
2 Biotech Stocks On Watch Early In The Week.....»»
Market Snapshot: Stocks poised to open lower, snap 2-session rise
U.S. stock futures head lower on Thursday, putting the indexes in position to end a two-day rise as investors digest quarterly results and watch for impacts from a nearly one-month partial shutdown of the government......»»
The Daily Biotech Pulse: Cancer Genetics Prices Offering, DiaMedica Delists From Canadian Exchange, Medigus CEO Quits
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks The following biotech stocks struck 52-week highs Jan. 9: read more.....»»
The Daily Biotech Pulse: BioMarin Trims Outlook, MediciNova Enrolls First Patient In Brian Cancer Drug Study
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peak (Biotech Stocks Hitting 52-week highs on Jan. 8) read more.....»»
Cancer stocks heat up after third big merger in the past month
The third multibillion-dollar bu.....»»
The Celgene Deal Shows How the Lines Between Biotech and Big Pharma Have Blurred
When it comes to the acquisition of cancer-treating upstarts, Bristol-Myers has been here before.....»»
3 of the Cheapest Drug Stocks You Can Buy in 2019
These biotech and pharma stocks are valued at or below eight times next year's profit projections......»»
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2018
HOUSTON, TX and VANCOUVER, Dec. 13, 2018 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSXV:EPI, NASDAQ:EPIX), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corpo.....»»
Is Intec Pharma a Sleeping Blockbuster Play?
The developmental biotech offers high reward, but for high riskRelated Stocks: NTEC,.....»»